Literature DB >> 2161827

A feline large granular lymphoma and its derived cell line.

C M Cheney1, J L Rojko, G J Kociba, M L Wellman, S P Di Bartola, L J Rezanka, L Forman, L E Mathes.   

Abstract

A lymphoma cell line (MCC) was derived from an abdominal mass from a 13-yr-old castrated male cat. The cells resemble natural killer precursor cells, have membrane-bound granules, and are positive for chloroacetate esterase, alpha-naphthyl butyrate esterase, and tartrate-resistant acid phosphatase activities. The MCC cells are negative for rearranged feline T-cell receptor genes, negative for feline T-cytotoxic antigen, Ia, and surface mu, tau, and lambda chains and do not form E-rosettes. The MCC cell line is negative for the feline leukemia virus (FeLV); e.g., negative for exogenous FeLV (exU3) sequences, negative for cytoplasmic and surface FeLV major core protein of 27,000 daltons (p27) by indirect immunofluorescence assay, negative for helper FeLV by clone 81 assay, and negative for release of soluble FeLV p27 by enzyme-linked immunosorbent assay. Electron microscopy reveals budding type C retrovirus particles and MCC cells react with anti-RD-114 (anti-endogenous feline retrovirus) reference serum. After in vitro infection, MCC replicate FeLV readily, but replication is noncytopathic.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161827     DOI: 10.1007/BF02624087

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  32 in total

1.  Correlation between humoral antibody and regression of tumours induced by feline sarcoma virus.

Authors:  M Essex; G Klein; S P Snyder; J B Harrold
Journal:  Nature       Date:  1971-09-17       Impact factor: 49.962

2.  Development of virus non-producer lymphosarcomas in pet cats exposed to FeLv.

Authors:  W D Hardy; A J McClelland; E E Zuckerman; H W Snyder; E G MacEwen; D Francis; M Essex
Journal:  Nature       Date:  1980-11-06       Impact factor: 49.962

3.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.

Authors:  Y Yanagi; Y Yoshikai; K Leggett; S P Clark; I Aleksander; T W Mak
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

4.  Guinea pig erythrocyte rosette formation as a nonspecific cell surface receptor assay in the cat.

Authors:  M L Wellman; G J Kociba; J L Rojko
Journal:  Am J Vet Res       Date:  1986-02       Impact factor: 1.156

5.  The U3 portion of feline leukemia virus DNA identifies horizontally acquired proviruses in leukemic cats.

Authors:  J W Casey; A Roach; J I Mullins; K B Burck; M O Nicolson; M B Gardner; N Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  Natural cell-mediated cytotoxicity in the domestic cat: properties and specificity of effector cells.

Authors:  M B Tompkins; K Huber; W A Tompkins
Journal:  Am J Vet Res       Date:  1983-08       Impact factor: 1.156

7.  Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses.

Authors:  P J Fischinger; C S Blevins; S Nomura
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

8.  Recovery of feline leukaemia virus from non-viraemic cats.

Authors:  B R Madewell; O Jarrett
Journal:  Vet Rec       Date:  1983-04-09       Impact factor: 2.695

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Development and distribution of B lineage cells in the domestic cat: analysis with monoclonal antibodies to cat mu-, gamma-, kappa-, and lambda-chains and heterologous anti-alpha antibodies.

Authors:  F W Klotz; W E Gathings; M D Cooper
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

View more
  15 in total

1.  Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.

Authors:  James H Morrison; Rebekah B Guevara; Adriana C Marcano; Dyana T Saenz; Hind J Fadel; Daniel K Rogstad; Eric M Poeschla
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

2.  Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.

Authors:  Ariko Miyake; Junna Kawasaki; Ha Ngo; Isaac Makundi; Yutaro Muto; Arshad H Khan; Desmond J Smith; Kazuo Nishigaki
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

3.  Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus.

Authors:  Brian J Willett; Elizabeth L McMonagle; Nicola Logan; Pascal Schneider; Margaret J Hosie
Journal:  Mol Immunol       Date:  2009-02-01       Impact factor: 4.407

4.  Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody.

Authors:  Brian J Willett; Martin Kraase; Nicola Logan; Elizabeth L McMonagle; Ayman Samman; Margaret J Hosie
Journal:  Retrovirology       Date:  2010-04-26       Impact factor: 4.602

5.  Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9.

Authors:  B J Willett; M J Hosie; O Jarrett; J C Neil
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

6.  Pathogenicity induced by feline leukemia virus, Rickard strain, subgroup A plasmid DNA (pFRA).

Authors:  H Chen; M K Bechtel; Y Shi; A Phipps; L E Mathes; K A Hayes; P Roy-Burman
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor.

Authors:  M J Hosie; B J Willett; T H Dunsford; O Jarrett; J C Neil
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

8.  Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses.

Authors:  A S McDougall; A Terry; T Tzavaras; C Cheney; J Rojko; J C Neil
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

9.  Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligand.

Authors:  Brian J Willett; Elizabeth L McMonagle; Nicola Logan; O Brad Spiller; Pascal Schneider; Margaret J Hosie
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

10.  Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus.

Authors:  Brian J Willett; Elizabeth L McMonagle; Susan Ridha; Margaret J Hosie
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.